Gradient Elution HPLC for Polypeptide Mixture Component Separation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for analyzing glatiramer acetate, a synthetic peptide mixture used to treat multiple sclerosis, face challenges in effectively separating and identifying its components due to its high continuity structure, making it difficult to distinguish between imitation and commercial products using single separation methods.
Innovation Solution
A high-performance liquid chromatography method involving linear or stepped gradient elution is employed, using reversed-phase liquid chromatography with specific chromatographic conditions such as C18-bonded silica particles, acetonitrile as mobile phase A, and ammonium sulfate as mobile phase B, along with UV or fluorescence detection to determine the content of each component by comparing peak areas with a reference substance.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If a size exclusion method is used for simple separation and analysis, then the separation process is simplified, but the ability to clarify various components of glatiramer acetate is insufficient
Solution Approach 1:
The patent applies parameter changes by systematically varying chromatographic conditions including mobile phase composition (acetonitrile concentration gradients from 5% to 40%), pH values (2-3), buffer types (ammonium sulfate, trifluoroacetic acid), and column temperatures (25-50°C) to achieve effective separation of glatiramer acetate components that cannot be resolved by size exclusion alone
Solution Approach 2:
The patent segments the separation process into multiple distinct chromatographic methods: anion exchange chromatography, cation exchange chromatography, and reversed-phase chromatography. Each method targets specific components based on their unique properties (charge, polarity), allowing comprehensive component analysis that a single size exclusion method cannot achieve
2Ease of operation
If only one separation method is used, then the analysis process is simpler, but it is difficult to clarify the various components of glatiramer acetate
Solution Approach 1:
The patent establishes a multi-functional analytical system where different chromatographic methods serve complementary purposes: anion exchange separates based on negative charge, cation exchange separates based on positive charge, and reversed-phase separates based on hydrophobicity. This universal approach ensures all component types can be identified through at least one appropriate method
Solution Approach 2:
The patent employs dynamic gradient elution in reversed-phase chromatography where the acetonitrile concentration increases progressively (5% to 40% over 50-250 minutes) to dynamically adjust separation power throughout the analysis, allowing both early-eluting and late-eluting components to be resolved in a single run
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for effective separation and analysis of glatiramer acetate components, ensuring the content of each component is within a qualified range, facilitating comparative analysis and quality assessment of the product.
Implementation Method 1
performing gradient elution on a sample to be tested with a reversed-phase liquid chromatography; C18-bonded, C12-bonded, C8-bonded, or C4-bonded silica particle with a particle diameter of 1.7-10 μm is used as a packing material for a chromatographic column
Implementation Method 2
The detection analysis in step (3) uses an ultraviolet detector to detect a wavelength of 260-280 nm
Data Source
AI summary
The present invention relates to a high performance liquid chromatography method for polypeptide mixtures. Specifically, the method including the following steps: step (1): preparing a solution of the glatiramer acetate to be tested; step (2): performing gradient elution on a sample to be tested with a reversed-phase liquid chromatography; step (3): determining a peak area corresponding to each component of the glatiramer acetate , comparing the peak area with to a peak area of a reference substance to determine whether the content of each component of the sample to be tested is in a qualified range.